Share resources to support your colleagues in West Africa     Join the Ebola Response Community

Controversial new evidence suggests that mammography screening for women in high-income nations may have diminishing value in light of effective modern treatment options. But for women in lower-income nations, mammography screening is not enough of a priority, treatment is poor and women face greater risk.

EXPERT PARTICIPANTS

Flavia Bustreo, Assistant Director-General, Family and Community Health, World Health Organization

Felicia Knaul, Director of the Harvard Global Equity Initiative, Secretariat of the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries

Mette Kalager, Researcher and lead author of The New England Journal of Medicine article offering a new assessment of mammography's effectiveness in reducing death rates. She also is a surgeon at Oslo University Hospital and is a visiting scientist at HSPH.

Julie Gralow, Professor and Director, Breast Medical Oncology, University of Washington / Seattle Cancer Care Alliance, and Associate Member, Fred Hutchinson Cancer Research Institute

MODERATOR

Abigail Trafford: Author and Former Health Editor, The Washington Post

Attached resource:

Link leads to: http://www.hsph.harvard.edu/forum/andelot-mammogram.cfm

Summary: Controversial new evidence suggests that mammography screening for women in high-income nations may have diminishing value in light of effective modern treatment options. But for women in lower-income nations, mammography screening is not enough of a priority, treatment is poor and women face greater risk.

EXPERT PARTICIPANTS

Flavia Bustreo, Assistant Director-General, Family and Community Health, World Health Organization

Felicia Knaul, Director of the Harvard Global Equity Initiative, Secretariat of the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries

Mette Kalager, Researcher and lead author of The New England Journal of Medicine article offering a new assessment of mammography's effectiveness in reducing death rates. She also is a surgeon at Oslo University Hospital and is a visiting scientist at HSPH.

Julie Gralow, Professor and Director, Breast Medical Oncology, University of Washington / Seattle Cancer Care Alliance, and Associate Member, Fred Hutchinson Cancer Research Institute

MODERATOR

Abigail Trafford: Author and Former Health Editor, The Washington Post

Source: Harvard School of Public Health

Language: English

Keywords: cancer, Conferences & Meetings

 
  Sign in to reply